BR0110943A - Derivados de dissulfeto úteis para o tratamento de doenças alérgicas - Google Patents
Derivados de dissulfeto úteis para o tratamento de doenças alérgicasInfo
- Publication number
- BR0110943A BR0110943A BR0110943-0A BR0110943A BR0110943A BR 0110943 A BR0110943 A BR 0110943A BR 0110943 A BR0110943 A BR 0110943A BR 0110943 A BR0110943 A BR 0110943A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- disulfide derivatives
- allergic diseases
- derivatives useful
- useful
- Prior art date
Links
- 150000002019 disulfides Chemical class 0.000 title abstract 2
- 208000026935 allergic disease Diseases 0.000 title 1
- 230000000172 allergic effect Effects 0.000 abstract 2
- 208000010668 atopic eczema Diseases 0.000 abstract 2
- GUUVPOWQJOLRAS-UHFFFAOYSA-N Diphenyl disulfide Chemical class C=1C=CC=CC=1SSC1=CC=CC=C1 GUUVPOWQJOLRAS-UHFFFAOYSA-N 0.000 abstract 1
- 208000030880 Nose disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 210000003630 histaminocyte Anatomy 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
- C07C323/44—X or Y being nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20582700P | 2000-05-19 | 2000-05-19 | |
| PCT/US2001/013331 WO2001090060A1 (en) | 2000-05-19 | 2001-04-25 | Disulfide derivatives useful for treating allergic diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0110943A true BR0110943A (pt) | 2004-01-06 |
Family
ID=22763799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0110943-0A BR0110943A (pt) | 2000-05-19 | 2001-04-25 | Derivados de dissulfeto úteis para o tratamento de doenças alérgicas |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US6492552B2 (https=) |
| EP (1) | EP1282599B1 (https=) |
| JP (1) | JP2003534318A (https=) |
| KR (1) | KR20030007589A (https=) |
| CN (2) | CN1241912C (https=) |
| AR (1) | AR028566A1 (https=) |
| AT (1) | ATE330938T1 (https=) |
| AU (2) | AU2001255675B2 (https=) |
| BR (1) | BR0110943A (https=) |
| CA (1) | CA2407964A1 (https=) |
| CY (1) | CY1105164T1 (https=) |
| DE (1) | DE60120961T2 (https=) |
| DK (1) | DK1282599T3 (https=) |
| ES (1) | ES2261402T3 (https=) |
| MX (1) | MXPA02011481A (https=) |
| PL (1) | PL365457A1 (https=) |
| PT (1) | PT1282599E (https=) |
| WO (1) | WO2001090060A1 (https=) |
| ZA (1) | ZA200208840B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5722701A (en) * | 2000-05-19 | 2001-12-03 | Alcon Universal Ltd | Aniline disulfide derivatives for treating allergic diseases |
| US7645903B2 (en) | 2002-10-31 | 2010-01-12 | Ge Healthcare Bio-Sciences Ab | Use of urea variants as affinity ligands |
| BRPI0512732A (pt) * | 2004-06-28 | 2008-04-08 | Alcon Inc | formulações tópicas para tratamento de doenças alérgicas |
| US20060217525A1 (en) * | 2004-12-22 | 2006-09-28 | Wright Davis Biomedical Technologies, Inc. | Degradable polymers and methods of preparation thereof |
| NZ618331A (en) * | 2011-06-17 | 2016-04-29 | Halozyme Inc | Stable formulations of a hyaluronan-degrading enzyme |
| US20130011378A1 (en) | 2011-06-17 | 2013-01-10 | Tzung-Horng Yang | Stable formulations of a hyaluronan-degrading enzyme |
| FR3057264B1 (fr) | 2016-10-12 | 2020-05-29 | Arkema France | Composes porteurs de groupes associatifs azotes |
| CN108586299B (zh) * | 2018-06-06 | 2020-06-16 | 北京化工大学 | 一种可引发、聚合及降低体积收缩的芳香二硫化合物的制备方法及用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1232787A (https=) | 1967-08-08 | 1971-05-19 | ||
| US3663616A (en) | 1969-10-13 | 1972-05-16 | Sherwin Williams Co | Bis(2-carbamylphenyl)disulfides |
| DE2967337D1 (en) | 1978-06-16 | 1985-02-07 | Kyowa Hakko Kogyo Kk | Antithrombotic pharmaceutical preparation containing 2,2'-dithiobis benzamide derivatives and new 2,2'-dithiobis benzamide derivatives |
| US4923892A (en) | 1985-08-17 | 1990-05-08 | Burroughs Wellcome Co. | Tricyclic aromatic compounds |
| GB8520662D0 (en) | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
| JPS6310784A (ja) | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
| GB9020933D0 (en) | 1990-09-26 | 1990-11-07 | Ici Plc | Compound,preparation and use |
| US5859017A (en) | 1994-04-01 | 1999-01-12 | Cell Therapeutics, Inc. | Method for inhibiting mast cell and basophil activation |
| US5463122A (en) | 1994-08-05 | 1995-10-31 | Warner-Lambert Company | Arylthio compounds |
| US5734081A (en) | 1994-08-05 | 1998-03-31 | Warner-Lambert Company | Arylthio compounds |
| US6001555A (en) | 1994-09-23 | 1999-12-14 | The United States Of America As Represented By The Department Of Health And Human Services | Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein |
| JPH095926A (ja) * | 1995-04-18 | 1997-01-10 | Fuji Photo Film Co Ltd | 熱現像感光材料 |
| US5641805A (en) | 1995-06-06 | 1997-06-24 | Alcon Laboratories, Inc. | Topical ophthalmic formulations for treating allergic eye diseases |
| US6225327B1 (en) | 1996-04-18 | 2001-05-01 | Alcon Laboratories, Inc. | Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications |
| JP2894445B2 (ja) | 1997-02-12 | 1999-05-24 | 日本たばこ産業株式会社 | Ｃｅｔｐ活性阻害剤として有効な化合物 |
| JP3940201B2 (ja) | 1997-05-20 | 2007-07-04 | 大塚製薬株式会社 | ３，３’−ジチオジベンゾヒドロキサム酸 |
-
2001
- 2001-04-25 DK DK01928863T patent/DK1282599T3/da active
- 2001-04-25 KR KR1020027014929A patent/KR20030007589A/ko not_active Withdrawn
- 2001-04-25 DE DE60120961T patent/DE60120961T2/de not_active Expired - Fee Related
- 2001-04-25 EP EP01928863A patent/EP1282599B1/en not_active Expired - Lifetime
- 2001-04-25 CA CA002407964A patent/CA2407964A1/en not_active Abandoned
- 2001-04-25 CN CNB200410073926XA patent/CN1241912C/zh not_active Expired - Fee Related
- 2001-04-25 BR BR0110943-0A patent/BR0110943A/pt not_active IP Right Cessation
- 2001-04-25 AU AU2001255675A patent/AU2001255675B2/en not_active Ceased
- 2001-04-25 PL PL01365457A patent/PL365457A1/xx not_active Application Discontinuation
- 2001-04-25 AT AT01928863T patent/ATE330938T1/de not_active IP Right Cessation
- 2001-04-25 PT PT01928863T patent/PT1282599E/pt unknown
- 2001-04-25 MX MXPA02011481A patent/MXPA02011481A/es active IP Right Grant
- 2001-04-25 AU AU5567501A patent/AU5567501A/xx active Pending
- 2001-04-25 US US09/841,859 patent/US6492552B2/en not_active Expired - Fee Related
- 2001-04-25 JP JP2001586249A patent/JP2003534318A/ja not_active Ceased
- 2001-04-25 CN CNB018094775A patent/CN1175807C/zh not_active Expired - Fee Related
- 2001-04-25 ES ES01928863T patent/ES2261402T3/es not_active Expired - Lifetime
- 2001-04-25 WO PCT/US2001/013331 patent/WO2001090060A1/en not_active Ceased
- 2001-05-15 AR ARP010102303A patent/AR028566A1/es not_active Application Discontinuation
-
2002
- 2002-05-22 US US10/153,716 patent/US6506802B2/en not_active Expired - Fee Related
- 2002-05-22 US US10/152,646 patent/US6500864B1/en not_active Expired - Fee Related
- 2002-10-31 ZA ZA200208840A patent/ZA200208840B/en unknown
-
2006
- 2006-08-23 CY CY20061101174T patent/CY1105164T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1175807C (zh) | 2004-11-17 |
| US20020193633A1 (en) | 2002-12-19 |
| ZA200208840B (en) | 2003-12-02 |
| PT1282599E (pt) | 2006-08-31 |
| DE60120961D1 (de) | 2006-08-03 |
| CA2407964A1 (en) | 2001-11-29 |
| AU5567501A (en) | 2001-12-03 |
| US6492552B2 (en) | 2002-12-10 |
| ATE330938T1 (de) | 2006-07-15 |
| AU2001255675B2 (en) | 2005-04-14 |
| CN1241912C (zh) | 2006-02-15 |
| CN1429209A (zh) | 2003-07-09 |
| DK1282599T3 (da) | 2006-07-31 |
| US20020193634A1 (en) | 2002-12-19 |
| US6506802B2 (en) | 2003-01-14 |
| MXPA02011481A (es) | 2003-06-06 |
| DE60120961T2 (de) | 2006-11-16 |
| ES2261402T3 (es) | 2006-11-16 |
| CN1616422A (zh) | 2005-05-18 |
| AR028566A1 (es) | 2003-05-14 |
| KR20030007589A (ko) | 2003-01-23 |
| WO2001090060A1 (en) | 2001-11-29 |
| EP1282599B1 (en) | 2006-06-21 |
| HK1050185A1 (en) | 2003-06-13 |
| JP2003534318A (ja) | 2003-11-18 |
| US20020058709A1 (en) | 2002-05-16 |
| US6500864B1 (en) | 2002-12-31 |
| PL365457A1 (en) | 2005-01-10 |
| EP1282599A1 (en) | 2003-02-12 |
| CY1105164T1 (el) | 2010-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0314319A (pt) | Transferência de gene mediada por vetor lentiviral e usos da mesma | |
| CY1112444T1 (el) | Χρηση των παραγωγων σουλφαμιδιου βενζο-συντηγμενου ετεροκυκλου ως νευροπροστατευτικοι παραγοντες | |
| BR0310100A (pt) | métodos para tratar, prevenir ou reduzir a lesão de reperfusão isquêmica em um tecido ou órgão, e para prevenir ou tratar de uma condição associada com a privação de oxigênio, seguida por suprimento de oxigênio aumentado a um tecido ou órgão em necessidade disto | |
| BRPI0401768A (pt) | Método de tratamento de um animal não-humano, e, método para reduzir a ocorrência de febre de transporte de gado bovino | |
| BRPI0502346A (pt) | processo de tratamento cosmético para prevenir e/ou tratar as peles sensìveis e/ou secas, utilização de uma quantidade eficaz de pelo menos um microorganismo notadamente probiótico e/ou uma de suas frações e/ou um de seus metabólitos e composição cosméticas e/ou dermatológica | |
| MY147643A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
| BR0212252A (pt) | Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero | |
| BR0209922A (pt) | Método para tratar uma condição médica que envolve a angiogênese em um paciente, para inibir a vascularização de células endoteliais, e para tratar câncer em um mamìfero | |
| BR0110943A (pt) | Derivados de dissulfeto úteis para o tratamento de doenças alérgicas | |
| AU2101800A (en) | Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis | |
| BRPI0410419A (pt) | tratamento para a ansiedade com ziprasidona | |
| BR0107628A (pt) | l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial | |
| WO2007095613A3 (en) | Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents | |
| BRPI0416445A (pt) | método para tratar um substrato de modo a aperfeiçoar a repelência ao álcool do substrato, substrato, tecido para controle de infecção e laminado de tecido não tramado | |
| BR0110845A (pt) | Derivados de dissulfeto de anilina para o tratamento de doenças alérgicas | |
| EP1478660A4 (en) | KAPPA-PVIIA-RELATED CONOTOXINS AS ORGAN PROTECTIVE AGENTS | |
| BR0004813A (pt) | Constructos vesiculares marcados para citoproteção e tratamento de infecções por h. pylori | |
| BR0110852A (pt) | Composições que contêm um derivado dissulfeto de benzamida para tratamento de doenças alérgicas | |
| DE60232154D1 (de) | Prophylaktische und therapeutische verwendung von hydroxysteroiden | |
| CN221450953U (zh) | 一种复合式灭菌创口贴 | |
| PT1232173E (pt) | Derivados do acido fusidico | |
| UA96747C2 (ru) | Применение бензоконденсированных гетероциклических сульфамидных производных как нейропротективных агентов | |
| BR0205625C1 (pt) | Formulações nasais em gel | |
| SE9901273D0 (sv) | Novel compounds | |
| WO2007131488A3 (de) | Verwendung von chinolonderivaten als anti-protozoäre mittel und in kombinatinonspräparaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009. |